Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature

Yousra Azzazi; Heba Ahmed Abdelkader; Hadeer Khedr; Mohamed H M El-Komy

doi:10.1111/cup.14235

Extensive cutaneous leukocytoclastic vasculitis after Sinopharm vaccine: Case report and review of the literature

J Cutan Pathol. 2022 Aug;49(8):736-742. doi: 10.1111/cup.14235. Epub 2022 Apr 27.

Authors

Yousra Azzazi¹, Heba Ahmed Abdelkader¹, Hadeer Khedr¹, Mohamed H M El-Komy¹

Affiliation

¹ Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.

PMID: 35355299
DOI: 10.1111/cup.14235

Abstract

Cutaneous leukocytoclastic vasculitis (LCV) has been reported as a rare form of cutaneous reaction to different SARS-Cov-2 vaccines. Herein, we present the first case of cutaneous LCV following BBIBP-CorV (Sinopharm) vaccine that occurred in a female patient with no prior comorbidities. A literature review about similar cases following different COVID-19 vaccines is discussed.

Keywords: BBIBP-CorV vaccine; COVID vaccine; Sinopharm; vasculitis.

Publication types

Case Reports
Review

MeSH terms

COVID-19 Vaccines
COVID-19*
Female
Humans
SARS-CoV-2
Vasculitis, Leukocytoclastic, Cutaneous* / chemically induced

Substances

COVID-19 Vaccines